In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
Israa M. Shamkh(R2M Solution (Italy)), Nour El-Houda A. Reyad(Cairo University), Dina Pratiwi(Universitas Muhammadiyah Tangerang), Hanaa S. Omar(Cairo University)
Cited by 1
Related Papers
A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
|Molecules|2021|58
Multi-Epitope Vaccine Design against Monkeypox Virus via Reverse Vaccinology Method Exploiting Immunoinformatic and Bioinformatic Approaches
|Vaccines|2022|45
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies
|Scientific Reports|2023|23
In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19
|Vaccines|2022|17
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors
|Journal of Biomolecular Structure and Dynamics|2023|16